Bret Jensen is the lead analyst for small-cap and large-cap stocks at Investors Alley. He was recently ranked in the top 1% of contributors with Seeking Alpha and is also regular contributor to TheStreet.com’s Real Money and TalkMarkets, in addition to his primary duties with Investors Alley. Formerly, Mr. Jensen was a technology director for American Express for over two decades before becoming chief investment strategist and co-founder of Simplified Asset Management, a specialty long/short hedge fund, which was ranked in the top 5% for total return during its first year. He is now the editor of Biotech Gems and Growth Stock Advisor.
Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.